miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis Zhuo ZhangHanxu ZhangYimin Cui Review 21 June 2022 Pages: 483 - 505
Allogeneic hematopoietic cell transplantation in patients with a hematologic malignancy and a prior history of breast cancer Kristine DoneyWendy LeisenringHannah Linden Review 02 July 2022 Pages: 507 - 516
Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer Lili ChenYanyang ChenZunfu Ke Preclinical study 05 July 2022 Pages: 517 - 529
Tumor-associated mononuclear cells in the tumor bed of triple-negative breast cancer associate with clinical outcomes in the post-neoadjuvant chemotherapy setting Thaer KhourySaif AljababShipra Gandhi Clinical trial 18 June 2022 Pages: 531 - 540
Awareness of link between obesity and breast cancer risk is associated with willingness to participate in weight loss intervention Laura BurkbauerMacy GoldbachJulia Tchou Clinical trial 25 June 2022 Pages: 541 - 550
Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxel Ciao-Sin ChenEllen M. Lavoie SmithDaniel L. Hertz Clinical trial 28 June 2022 Pages: 551 - 560
Risk of secondary malignancy after radiotherapy for breast cancer: long-term follow-up of Japanese patients with breast cancer Noriyuki OkonogiKumiko KarasawaHiroshi Tsuji Clinical trial Open access 04 July 2022 Pages: 561 - 567
Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer Neelima VidulaChristina YauHope Rugo Clinical trial 04 July 2022 Pages: 569 - 575
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer Ida SkarpingKristoffer NilssonLisa Rydén Clinical trial Open access 05 July 2022 Pages: 577 - 586
Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer L. CorkeL. LuzhnaN. LeVasseur Epidemiology 15 June 2022 Pages: 587 - 595
Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis Tal SellaPedro ExmanErica L. Mayer Epidemiology 17 June 2022 Pages: 597 - 606
Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density Karen J. WernliRebecca E. SmithAnna N. A. Tosteson Epidemiology 20 June 2022 Pages: 607 - 616
Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence R. HaarsmaA. A. van LoevezijnF. H. van Duijnhoven Epidemiology 21 June 2022 Pages: 617 - 627
Long-term survival in elderly women receiving chemotherapy for non-metastatic breast cancer: a population-based analysis Matthew CasteloJustin LuAdena S. Scheer Epidemiology 22 June 2022 Pages: 629 - 641
Racial and ethnic disparities in the refusal of surgical treatment in women 40 years and older with breast cancer in the USA between 2010 and 2017 Pierre FweloZenab I. YusufXianglin L. Du Epidemiology Open access 24 June 2022 Pages: 643 - 661
The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy Tal SellaOlga KantorTari A. King Epidemiology 25 June 2022 Pages: 663 - 672
Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations Ashley M. GeczikJennifer S. FerrisJeanine M. Genkinger Epidemiology 02 July 2022 Pages: 673 - 682
Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy Jong-Ho CheunYoung Joo LeeJeong Eon Lee Original Article 28 June 2022 Pages: 683 - 692
Surveillance mammography after treatment for male breast cancer Siddhartha YadavLindsey SangaralinghamKathryn J. Ruddy Brief Communication 17 June 2022 Pages: 693 - 698
A mixed method study of medical oncologists’ perceived barriers and motivators to addressing long-term effects in breast cancer survivors Alex J. FauerPatricia A. GanzEden R. Brauer Brief Communication Open access 29 June 2022 Pages: 699 - 707
Comment on “Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta‑analysis” Francesca PoggioMarcello CeppiMarco Tagliamento Letter to the Editor 24 June 2022 Pages: 709 - 710